CDSCO License for Diagnostic Software, K- Nearest Neighbor Algorithm, Autoimmune Disease
Medical Device Information
Intended Use
The device is intended to suggest a systemic autoimmune disease association as an aid for differential diagnosis to be evaluated in conjunction with clinical findings and other laboratory tests.

Introduction: Diagnostic Software for Autoimmune Disease and Regulatory Significance
Navigating the regulatory landscape for medical software devices in India can be intricate, especially for specialized diagnostic tools like the K-Nearest Neighbor (K-NN) Algorithm designed for autoimmune disease association. This software supports clinicians in differential diagnosis by suggesting systemic autoimmune disease correlations, complementing clinical and laboratory findings. Given its critical role in healthcare decision-making, obtaining a valid CDSCO license is not just mandatory but essential to ensure compliance, patient safety, and market access.
With over 25 years of experience and having successfully assisted 500+ companies, we specialize in guiding manufacturers and importers through the complexities of CDSCO licensing for medical software devices, specifically Class B devices like this diagnostic software.
CDSCO Regulatory Framework for Diagnostic Software (K-NN Algorithm)
The Central Drugs Standard Control Organization (CDSCO) regulates medical devices under the Medical Device Rules (MDR) 2017. Diagnostic software falls under the category of Software as a Medical Device (SaMD) and is subject to licensing requirements based on risk classification. This device, classified as Class B, is a moderate-risk device requiring a manufacturing license (MD5) from the State Licensing Authority.
The relevant notification for this device is 29/Misc./03/2020-DC (198), dated 13.9.2021, which officially includes diagnostic software under the CDSCO purview.
Risk Classification and License Requirements for Class B Software
Class B devices are considered low to moderate risk. For such devices, the CDSCO mandates an MD5 license, which involves a multi-step process including test license acquisition, product testing, documentation, audit by a notified body, and final license grant.
This ensures that your diagnostic software meets essential safety, quality, and performance criteria before entering the Indian market.
Manufacturing License Process (MD5) for Diagnostic Software
The MD5 license process for Class B software includes these critical steps:
Test License (Form MD13): Apply for a test license to allow product testing. This takes approximately 1.5 to 2 months.
Product Testing: Get the software tested at CDSCO-approved laboratories for compliance with standards.
Documentation Preparation: Compile Device Master File, Plant Master File, Risk Management File, Essential Principles Checklist, and QMS documents.
License Application (Form MD3): Submit the manufacturing license application.
Audit by Notified Body: A notified body conducts an on-site audit of your manufacturing facility and quality systems.
Query Resolution: Respond promptly to any queries from CDSCO or the notified body.
Grant of License (Form MD5): Upon successful compliance, CDSCO issues the manufacturing license.
For a detailed overview, refer to our MD5 License Guide.
Manufacturing License Documents Required for Diagnostic Software
To facilitate a smooth application, ensure you have the following documents ready:
- Company Constitution (e.g., Certificate of Incorporation)
- Proof of Ownership or Lease of Manufacturing Premises
- Details and Qualification Certificates of Technical Staff
- Fire and Pollution NOCs
- Device Master File (DMF) detailing software design, development, and validation (Device Master File Guide)
- Plant Master File outlining manufacturing environment and processes (Plant Master File Guide)
- Essential Principles Checklist demonstrating compliance with MDR 2017
- Risk Management File highlighting hazard analysis and mitigation (Risk Management)
- Test Reports from CDSCO-approved laboratories (Testing Laboratories)
- Product Labels and Instructions for Use (IFU)
- Quality Management System (QMS) Documents compliant with ISO 13485:2016
Import License Process (MD15) for Diagnostic Software
If you plan to import this software into India, you must obtain an MD15 import license from the Central Licensing Authority. The process includes:
- Document preparation including Manufacturing License, Free Sale Certificate, ISO 13485:2016 certification, CE Certificate, DMF, Plant Master File, and Wholesale License.
- Submission of application on the CDSCO MD Online Portal using Form MD14.
- Resolution of any queries raised.
- Grant of Import License (Form MD15).
The import license process typically takes 5-6 months. Detailed guidance is available in our Import License Guide.
Import License Documents Required
- Valid Manufacturing License from the country of origin
- Free Sale Certificate
- ISO 13485:2016 Certification
- CE Certificate (if applicable)
- Device Master File and Plant Master File
- Wholesale License
- Company Constitution
Timeline and Processing Duration
Step | Duration |
---|---|
Test License (MD13) | 1.5 - 2 months |
Product Testing | 1 - 1.5 months |
Documentation & Application | 2 - 3 weeks |
Audit by Notified Body | 2 - 3 weeks |
Query Resolution & Final Grant | 2 - 4 weeks |
Total Estimated Time for MD5 License: Approximately 3 to 4 months.
For imports (MD15), the process usually takes 5 to 6 months.
Government Fees and Costs
For Class B devices like the Diagnostic Software:
- MD5 Manufacturing License: Rs 5,000 per application + Rs 500 per product.
- Test License (MD13): Included within the MD5 process cost.
- Audit Fees: Typically borne by the manufacturer; notified bodies charge separately based on scope.
For import licenses (MD15), fees vary by device class and product count; typically higher than manufacturing licenses.
Common Challenges and Solutions
Challenge 1: Documentation Gaps
Many applicants struggle with preparing comprehensive Device Master Files and Risk Management Files.
Solution: Utilize detailed templates and checklists; engage experts early to ensure all software-specific validations and risk analyses meet CDSCO expectations.
Challenge 2: Prolonged Testing and Audit Delays
Limited CDSCO-approved labs and notified body availability can cause bottlenecks.
Solution: Schedule testing and audits proactively; select notified bodies from the official list early in the process.
Challenge 3: Query Management
Unclear or delayed responses to CDSCO queries can stall the process.
Solution: Develop a dedicated regulatory team to respond promptly with precise documentation and clarifications.
Expert Consultation and Support
With our 25+ years in CDSCO licensing and extensive experience with software-based medical devices, we provide end-to-end support including:
- Gap analysis of your current documentation
- Preparation of Device and Plant Master Files
- Coordination with testing laboratories and notified bodies
- Application preparation and submission via the CDSCO MD Online Portal
- Liaison for query resolution and compliance audits
Our proven approach ensures faster approvals and mitigates risks of non-compliance.
Getting Started with Your CDSCO License Application
Assess your Device Classification: Confirm your device is Class B per the Medical Device Classification guidelines.
Gather Preliminary Documents: Company Constitution, proof of premises, and technical staff details.
Initiate Test License Application (Form MD13): Submit via CDSCO MD Online Portal.
Plan Product Testing: Book slots with CDSCO-approved labs.
Develop Key Files: Device Master File and Risk Management File tailored to your diagnostic software.
Schedule Notified Body Audit: Choose from the notified bodies list.
Prepare for Queries: Anticipate technical and compliance questions and have your team ready.
By following these actionable steps and leveraging our expertise, you can streamline your CDSCO licensing journey and successfully market your Diagnostic Software in India.
For personalized assistance, reach out to our expert regulatory consultants who have guided hundreds of companies through this exact process.